Production of biochemical marker substances by bronchogenic carcinomas.
D000324:Adrenocorticotropic Hormone / Q000378:metabolism; D000951:Antigens, Neoplasm / Q000378:metabolism; D002116:Calcitonin / Q000378:metabolism; D002128:Calcium Metabolism Disorders / Q000209:etiology; D002272:Carcinoembryonic Antigen / Q000378:metabolism; D002283:Carcinoma, Bronchogenic / Q000150:complications / Q000378:metabolism*; D005260:Female; D013006:Growth Hormone / Q000378:metabolism; D006728:Hormones / Q000378:metabolism; D006729:Hormones, Ectopic / Q000378:metabolism*; D006801:Humans; D007177:Inappropriate ADH Syndrome / Q000209:etiology; D008175:Lung Neoplasms / Q000150:complications / Q000378:metabolism*; D008297:Male; D009384:Paraneoplastic Endocrine Syndromes / Q000378:metabolism*; D010908:Pituitary Hormones, Anterior / Q000378:metabolism; D011379:Prognosis; D012635:Secretory Component / Q000378:metabolism; D014667:Vasopressins / Q000378:metabolism
D000951:Antigens, Neoplasm; D002272:Carcinoembryonic Antigen; D006728:Hormones; D006729:Hormones, Ectopic; D010908:Pituitary Hormones, Anterior; D012635:Secretory Component; D014667:Vasopressins; D000324:Adrenocorticotropic Hormone; D013006:Growth Hormone; D002116:Calcitonin